London/4th January – MediSieve, today announced that it is presenting virtually at the Biotech Showcase™ 2022 conference with an online presentation. This year, registered attendees to Biotech Showcase can access MediSieve’s recorded company presentation beginning the week of December 6th – five weeks prior to the actual event. 24x7 on-demand access allows attendees to view presentations at their convenience in case scheduling does not allow viewing during the main event week.
George Frodsham, Founder & CEO, will be presenting MediSieve at Biotech Showcase
Dr Frodsham will discuss the vast potential of the company's breakthrough therapy, Magnetic Haemofiltration, which will undergo a first-in-man trial in early 2022. This technology is a tool that enables doctors to remove specific things from the bloodstream of patients. It can be used either as a direct treatment, to increase the safety and efficacy of other therapies, or to enable personalised medicine. There are several multi-billion-dollar markets available for it in oncology, infectious diseases, auto-immune diseases, poisoning, drug overdose and others. MediSieve could lead the way to a future where these conditions pose far less of a threat to human health than they do right now.
“We are very pleased to be one of the Presenting Companies at the Biotech Showcase this year. MediSieve is at a very exciting stage and we are looking forward to sharing our progress and plans with potential investors at the event,” said George Frodsham, Founder and CEO of MediSieve.
Biotech Showcase, produced by Demy-Colton and EBD Group, is an investor conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters investment and partnership opportunities. The conference takes place each year during the course of one of the industry's largest gatherings and busiest weeks.
“We are delighted that MediSieve will be presenting at Biotech Showcase this year,” said Sara Demy, CEO of Demy-Colton. “Biotech Showcase is a prime occasion for life science entrepreneurs and investors to come together to discover the potential of innovative technologies that will drive the future of drug discovery.”
MediSieve will also participate and present in JP Morgan Week, which is the biggest series of events in the industry. In addition to the Biotech Showcase, MediSieve will also participate in IR@JPM Virtual Demo Day. The event will give MediSieve exposure to the industry's top investors. Furthermore, an event hosted by BioMedEng Association will allow the company to connect with major innovators and clinicians within the Biomedical Engineering space. MediSieve is excited to showcase its technology in front of the leading industry players.
ABOUT BIOTECH SHOWCASE
Biotech Showcase is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place. Investors and biopharmaceutical executives from around the world gather at Biotech Showcase during this bellwether week which sets the tone for the coming year. Now in its 14th year, this well-established, highly respected conference features multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings. Biotech Showcase is produced by Demy-Colton and EBD Group. Both organizations have a long history of producing high-quality programs that support the biotechnology and broader life sciences industry.
ABOUT MEDISIEVE
MediSieve is a biotech company, developing “Magnetic Blood Filtration”, a combination of a drug delivery device and a therapeutic platform of treating blood-borne diseases by removing pathogens, toxins or other targets directly from a patient’s bloodstream. From sepsis to malaria to leukaemia and viral infections, such as COVID-19, MediSieve has the ambition of providing hospitals with a tool to tackle some of mankind’s most serious diseases.
Contacts
info@medisieve.co.uk
Follow MediSieve on Twitter at @MediSieve and Biotech Showcase at @EBDGroup and @Demy_Colton and tag your posts with #BiotechShowcase.
MediSieve Announces First Volunteer Successfully Enrolled in Phase 1 Clinical Study July 08, 2022
MediSieve at Industry Events In June 2022 June 29, 2022